Previous close | 12.30 |
Open | 12.41 |
Bid | 11.83 x 100 |
Ask | 11.87 x 100 |
Day's range | 11.75 - 12.57 |
52-week range | 4.31 - 12.57 |
Volume | |
Avg. volume | 154,258 |
Market cap | 485.006M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.78 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 9.55 |
Natalie Holles, Chief Executive Officer of Third Harmonic Bio Inc (NASDAQ:THRD), sold 20,222 shares of the company on May 9, 2024.
Natalie Holles, CEO of Third Harmonic Bio Inc (NASDAQ:THRD), has sold 13,558 shares of the company on April 11, 2024, according to a recent SEC Filing.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...